My MPhil research at Cambridge, also funded by Gates Cambridge scholarship, looked into novel and biocompatible nanoparticles that potentially can be used to image cancer cells. Taking this one step further, for my PhD, I aim to rationally design and synthesize these nanoparticles to deliver anticancer drugs for the treatment of pancreatic cancer, one of the hard-to-treat cancers. I also want to see if we can embed diagnostic functionality to the nanoparticles, thus combining diagnostic and therapy into one single formulation. Not only that such a hybrid system will minimize side effects on the patients, but it will also enable monitoring of therapeutic responses which could further improve the treatment outcome.
It is my hope that results stemming from the project will have a positive impact on the academic community and open a way to pre-clinical studies for improving the efficacy of pancreatic cancer treatment.